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A collection of genomic DNA sequences of herpes simplex virus (HSV) strains has been deﬁned and
analyzed, and some information is available about genomic stability upon limited passage of viruses in
culture. The nature of genomic change upon extensive laboratory passage remains to be determined. In
this report we review the history of the HSV-1 KOS laboratory strain and the related KOS1.1 laboratory
sub-strain, also called KOS (M), and determine the complete genomic sequence of an early passage stock
of the KOS laboratory sub-strain and a laboratory stock of the KOS1.1 sub-strain. The genomes of the two
sub-strains are highly similar with only ﬁve coding changes, 20 non-coding changes, and about twenty
non-ORF sequence changes. The coding changes could potentially explain the KOS1.1 phenotypic prop-
erties of increased replication at high temperature and reduced neuroinvasiveness. The study also pro-
vides sequence markers to deﬁne the provenance of speciﬁc laboratory KOS virus stocks.
& 2015 Elsevier Inc. All rights reserved.Introduction
Viruses acquire mutations as they replicate, and the viruses
that emerge can be enhanced for replication, infection of the host
and transmission, persistence in the host, or evasion of the host
response. When viruses are taken from the normal host and
placed in culture, selection for rapidly growing viruses ﬁxes
mutations that pre-exist in the population (Luria and Delbrück,
1943) or arise spontaneously in the population and that favor
rapid replication in the host cells. Thus, during passage in culture
viruses acquire new genetic alleles.
The herpesviruses comprise a large family of enveloped,
double-stranded DNA viruses, several of which are important
human pathogens (Pellett and Roizman, 2013). In addition to
commonly causing labial and ocular disease, herpes simplex virus
1 (HSV-1) is the most common cause of sporadic viral encephalitis
as well as a cause of severe mucocutaneous disease in.M. Knipe).
eases, NIAID, Bethesda, MD,
itute, San Antonio, TX, Unitedimmunocompromized hosts. Infection results in lifelong presence
of latent virus in neural ganglia, and, because 60–90% of the
world's population is seropositive (Smith and Robinson, 2002),
HSV-1 could be considered an episome of the human genome in
certain neurons. The 150-kilobase pair genome of HSV-1 encodes
at least 84 protein-coding open reading frames, as well as the long
non-coding RNA latency-associated transcript and numerous
miRNAs (Roizman et al., 2013). The HSV linear double-stranded
DNA genomes consist of two covalent linked components, the long
(L) and short (S) components, which invert relative to each other
by intramolecular recombination (Roizman et al., 2013). The L
component consists of unique sequences (UL) bounded by inverted
repeats (RL and RL0), and the S component consists of the unique
sequences (US) bounded by inverted repeats (RS and RS0) (Fig. 1)
(Roizman et al., 1979). The termini contain direct repeats of a
sequence called the “a” sequence, and copies of this sequence are
present in an inverted form, designated the a0 sequence, at the L–S
junction (Hayward et al., 1975). The genomic structure can
therefore be diagrammed aLan-RL-UL-RL'-a'm-RS'-US-RS-aS (Roiz-
man et al., 2013).
HSV-1 has been studied extensively in vivo and in vitro,
including studies of genetic variation at the level of individual
genes, and in patterns of restriction-length polymorphisms
Fig. 1. Diagram of the structure of the herpes simplex virus genome. The top row
shows the long (L) component and the short (S) component of the HSV genome.
The bottom row shows the unique sequences as a line and the boxes denote the
repeated sequences. UL¼unique long component sequences; US¼unique short
component sequences; RL and RL'¼ inverted repeats bounding the long component;
RS and RS0 denote inverted repeats bounding the S component. a¼terminal repeat
also located at the L/S junction.
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published full genome sequence, however, had been that of HSV-1
strain 17 (McGeoch et al., 1988), a laboratory strain that has
undergone many passages in vitro. Recently, additional HSV-1
genomes have been reported (Szpara et al., 2014, 2010), which are
beginning to reveal more about the full range of genome sequence
variation among these viruses. Several different clades are appar-
ent, largely based on geographical origin of the isolates (Szpara et
al., 2014). Recent studies have shown that limited passage of HSV
strains in culture can lead to a limited number of sequence
changes in the virus (Colgrove et al., 2014), but we know less about
the effects of long-term passage of viruses in culture. In particular,
the HSV-1 KOS strain was disseminated to different laboratories
over a number of years, and a number of separate lineages or
substrains have arisen as a result of passage and plaque puriﬁca-
tion in these laboratories. These sub-strains show some differ-
ences in biological properties. Because of the differences in the
sub-strains, it is important to know and keep in mind the genetic
background of the KOS strains in use and the source of any DNA
sequences used for mutagenesis or rescue. The purpose of this
report is to review the history of the HSV-1 KOS sub-strains and to
provide a genome comparison of the two major laboratory sub-
strains, KOS and KOS1.1.
History of the HSV-1 KOS strain
HSV-1 KOS virus was originally isolated from a lip lesion of
Smith (1964) and ﬁrst described as the SOK strain. This strain was
chosen for laboratory studies because it had a low particle:PFU
ratio (Smith, 1964). The original isolate of KOS was also called KOS-
63 and was passaged in the laboratory. The prototype laboratory
strain KOS-63 and the low-passage clinical isolate KOS-79 were
isolated 16 years apart from recurrent lip lesions in the same
individual and thus were thought to be related. However,
biochemical analyses of these viruses revealed signiﬁcant differ-
ences in the patterns of virus-induced polypeptides as well as
differences in DNA restriction endonuclease cleavage patterns
(Dix et al., 1983). By one of the deﬁnitions used to deﬁne HSV-1
strains, differences in DNA restriction endonuclease cleavage sites
in non-repetitive sequences (Buchman et al., 1980), Dix et al.
(1983) concluded that “KOS-63 and KOS-79 could be considered to
be unique and unrelated strains of HSV-1.”
KOS virus, presumably a derivative of the KOS-63 virus, was
plaque-puriﬁed by Priscilla Schaffer three times at 35 °C and then
passaged three times at 40 °C to “eliminate preexisting ts virions”
prior to its use for genetic studies (Schaffer et al., 1970). A panel of
temperature-sensitive mutant viruses was isolated and char-
acterized by Schaffer et al. (1973) in the KOS virus genetic back-
ground, so it became a common laboratory wild-type strain. This
virus was also used to construct other types of mutants including
drug-resistant mutants (Coen and Schaffer, 1980) and deletion
mutants (DeLuca et al., 1985). This laboratory KOS strain has
sometimes been called KOS (H) because it was the prototype at
Baylor University in Houston, or KOS (Schaffer) because it was
popularized by Priscilla Schaffer with her ts mutants.The HSV-1 KOS genomic sequence has been reported in two
studies (Macdonald et al., 2012; Kinchington Genbank sequence).
Interestingly, Szpara et al. (2014) reported that KOS clustered with
an Asian HSV-1 strain by phylogenetic analysis. Grose (2014)
hypothesized that Smith acquired this virus when he served in
Korea during the Korean War, which could explain the origin of
this virus.
History of the KOS1.1 virus
Hughes and Munyon (1975) obtained HSV-1 KOS virus from
Edmundo Kraiselburd and plaque-puriﬁed it at 39 °C to generate what
they named the KOS1.1 virus. They isolated 12 temperature-sensitive
mutant viruses that represented 7 complementation groups (Hughes
and Munyon, 1975). Myron (Mike) Levine's laboratory used the KOS1.1
virus obtained from Hughes and Munyon (Adler et al., 1978) to isolate
a number of additional temperature-sensitive mutant viruses that
included the ts13, ts18, ts656, and tsLG4mutant viruses (Sandri-Goldin
et al., 1981). The KOS1.1 virus also served as the source of HSV-1 DNA
for construction of the pSG plasmids, which included nearly the entire
HSV-1 genome (Goldin et al., 1981). Levine provided KOS1.1 wt and ts
mutants to the Knipe laboratory in 1979–1980. The Knipe laboratory
constructed a series of ICP8 (Gao and Knipe, 1989) and ICP27 gene
mutant viruses (Rice and Knipe, 1990) in this genetic background.
Other derivatives of the KOS1.1 virus
Joe Glorioso's laboratory plaque-puriﬁed a virus from KOS1.1
that they called KOS 321 (Holland et al., 1983). In addition, Jack
Stevens obtained the HSV-1 KOS1.1 virus from Mike Levine's
laboratory, and his laboratory plaque-puriﬁed it and named it KOS
(M) to denote its origin as the University of Michigan (Thompson
et al., 1986). Certain later papers referred to this virus as KOS
(Yuhasz and Stevens, 1993). KOS (M) virus showed reduced neu-
roinvasion and reduced replication in spinal ganglia as compared
with HSV-1 strain 17 virus (Javier et al., 1986; Thompson et al.,
1986). The neuroinvasiveness defect in KOS (M) mapped to a
region of the glycoprotein B gene, and two amino acid residue
differences were reported in the KOS (M) gB gene relative to the
strain ANG gB gene, R485H and A523 V (Yuhasz and Stevens,
1993). The KOS (M) virus was used to make various mutants in the
Stevens, Wagner, Feldman, Thompson and Bloom laboratories,
including latency-associated transcript coding region mutants and
recombinants expressing reporter proteins from the LAT promoter
(Devi-Rao et al., 1994; Dobson et al., 1989; Izumi et al., 1989;
Sedarati et al., 1989). We had observed that the KOS1.1 virus
established latent infection very inefﬁciently (Morrison and Knipe,
unpublished results), so in this study we directly compared the
biological properties and genome sequences of an early passage
KOS virus and a KOS1.1 virus and deﬁned their genomic sequences.Results
Biological properties of the HSV-1 KOS and KOS1.1 viral stocks
We have used the HSV-1 KOS strain extensively for latency
studies in a murine model (Cliffe et al., 2009; Coen et al., 1989;
Leib et al., 1989a, 1989b; Wang et al., 2005), but we had also used
the HSV-1 KOS1.1 virus for genetic analysis (Gao and Knipe, 1989;
Rice and Knipe, 1990). We therefore wanted to compare the bio-
logical properties and genome sequence of the two sub-strains.
The HSV-1 KOS virus stock used for preparation of viral DNA was
obtained by amplifying a passage 12 stock provided by Dr. Priscilla
Schaffer, and the KOS1.1 virus stock used for preparation of viral
DNA for sequencing was approximately three passages from the
R.C. Colgrove et al. / Virology 487 (2016) 215–221 217stock originally provided by M. Levine. To test the biological
properties of these virus stocks, they were tested in the mouse
corneal model of infection (Leib et al., 1990). We observed viral eye
titers that were less than 2-fold higher for KOS as compared with
KOS1.1 (Fig. 2A), but latent viral DNA loads were 20-fold higher for
KOS as compared with KOS1.1 (Fig. 2B). These results showed the
KOS and KOS1.1 stocks used for our studies had biological prop-
erties similar to those previously observed for KOS (M) relative to
HSV-1 strain 17 virus (Javier et al., 1986; Thompson et al., 1986).
Genomic sequencing
The sequence of the KOS genome was determined by a com-
bination of Sanger sequencing, 454 sequencing, and Illumina
sequencing. The ﬁrst round of sequencing employed traditional
shotgun cloning and Sanger sequencing but achieved adequate
coverage of only one third of the genome with good read depth
and high-quality sequence. Under-represented regions showed a
highly non-random distribution in areas of particularly low
sequence complexity and high-GC content. Next-gen 454
sequencing (454 Life Sciences, Branford, CT) was then employed to
attempt to close gaps to give near-complete genome coverage
when merged with Sanger sequence data. The 454 data, however,
showed a number of length variations in homopolymeric stretches
within coding regions relative to the reference strain, which were
not present in the Sanger sequence data. A combination of auto-
mated assembly onto partial genome scaffolds corresponding to
UL, US, RL, and RS, and manual assembly of bridging reads from the
raw 454 data were required to generate full genome sequences.
The complete KOS sequence was derived for all 13 kilobases and
12 open reading frames of US. The remaining small gaps at the
termini, the junctions between unique and repeat regions, and in
ICP4 and ICP0 were closed using conventional sequencing of PCRFig. 2. In vivo phenotype of HSV-1 KOS and KOS1.1. Groups of mice (n¼30/group)
were infected with HSV-1 KOS or HSV-1 KOS1.1, as described in Materials and
methods. (A) Virus from eyeswabs of ﬁve HSV KOS- and ﬁve KOS1.1-infected mice
during acute infection was titrated on Vero cells. Shown are mean values and
standard error of the means. (B) Latent viral DNA from HSV KOS and KOS1.1-
infected mice at 30 days postinfection was quantiﬁed by real-time PCR relative to a
GAPDH cellular control gene during latent infection. Shown are the mean values
and standard error of the means.products or from the pK1-2 plasmid encoding the ICP4 gene
(DeLuca and Schaffer, 1987), and conﬁrmed by a subsequent run of
Ilumina sequencing. In the case of the "a" sequence (Varmuza and
Smiley, 1985) and the region around OriS (position 131870–
132250; (Weller et al., 1985), the gaps were ﬁlled in with the
indicated published KOS sequence. The numbers of repeated
sequences not deﬁned by the sequence data were assigned based
on the numbers in the HSV-1 strain 17 genomic sequence.
Our KOS genomic sequence (GenBank accession number
KT899744) was identical to two others reported previously, Gen-
Bank accession numbers JQ673480 (Macdonald et al., 2012) and
JQ780693.1 (Payne, Russell, and Kinchington, unpublished data).
The sequence identity was not surprising because Macdonald et al.
(2012) used a similar passage 12 virus stock from Priscilla Schaffer,
and the Kinchington sequence also used an early passage stock
from the Schaffer lab (personal communication). The KOS genome
sequence contained a previously reported stop codon in the US9
ORF (Negatsch et al., 2011).Comparison of the KOS and KOS1.1 genomes
The complete KOS1.1 genome (GenBank accession # KT887224)
was determined by Illumina sequencing and the numbers of
repeats were assigned based on the HSV-1 strain 17 reference
genome. The ORFs of the KOS and KOS1.1 genomes were highly
similar. There were a small number of non-coding changes, sum-
marized in Table 1. Only ﬁve coding changes in ORFs were
observed. These included the R515H codon change in the UL27
gene encoding glycoprotein B, the T566A codon change in the UL30
gene encoding the viral DNA polymerase catalytic subunit, the
UL36 sequence repeat number variation, the UL39 L383P codon
change, and the S81P codon change in the ICP4 or RS1 ORF
encoding the immediate-early ICP4 transcriptional regulator
(Table 2). These sequence changes could contribute to the
decreased neuroinvasion and increased thermostability of the
KOS1.1 virus, as described in Discussion.
ORF analysis relative to strain 17
We also compared the HSV-1 KOS sequence to the original
HSV-1 strain 17 reference (GenBank accession # NC_001806). Of
the 56 ORFs in UL, 12 ORFs in US and three in the long and short
repeats in the strain 17 sequence, all are present in KOS, and there
are no new large ORF's. Overall sequence conservation is high,
ranging from 95% to 100%. Nine genes show 100% identity
between KOS and strain 17 (Table 3). Of note, a majority of these
(UL16, 18, 20, 21, and 28) lie within a relatively small stretch of the
genome. Most of the sequence variation was accounted for by
single nucleotide polymorphisms, but 17 ORFs showed smallTable 1
List of non-coding changes between HSV KOS and KOS1.1.
US Two 1–2 nucleotide indels in homopolymeric intergenic regions
UL left1 62,387 out of 62,399 nucleotides identical
Four indels in homopolymeric non-coding regions
Two single-nucleotide and two 2-nucleotide silent changes
UL right 45,298 out of 45,303 nucleotides identical
No indels
Five silent transitions and 1 silent transversion
RS One silent transition in RS1
RL One silent transition Four single nucleotide indels in homopolymeric
regions
One 3 nucleotide deletion (just right of LAT intron in homopolymeric
run of A's)
1 UL left and UL right are divided at the repeat sequence in UL36.
Table 2
Differences between HSV KOS and KOS1.1 coding sequences n.
n Numbers show codon position relative to the AUG. Amino acid changes are shown in red and indels with (—).
Table 3
Genes with 100% identity between HSV-1 strains KOS and 17.
Gene Function Length (bp)
UL16 Tegument protein 1122
UL18 Capsid protein 957
UL20 Membrane protein 669
UL21 Tegument protein 1608
UL28 Terminase subunit 2358
UL35 Capsid protein 339
UL45 Membrane protein 519
UL55 Nonstructural protein 561
US8 Glycoprotein E 1653
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Several genes showed closely paired insertions and deletions
relative to the HSV-1 strain 17 reference sequence, which would
predict internal frameshifts and subsequent restoration of the
initial reading frame, resulting in short changes in predicted amino
acid sequence (Table 4). An additional pair of frameshifts in UL44
are translationally silent (not shown). These sequence differences
are similar to those reported by others (Szpara et al., 2010; Mac-
donald et al., 2012).Discussion
The HSV-1 KOS strain has been utilized by a number of labs and
passaged and re-plaque-puriﬁed as it has been disseminated into
new labs. The KOS1.1 or KOS (M) sub-strain was selected for growth
at higher temperature and has been shown to be less neuroinvasive
than the original KOS virus, but the genetic basis for the phenotypic
differences has not been deﬁned completely. Here we report the
genome sequence for HSV KOS and its derivative KOS1.1 sub-strain,
which are closely related but show a few signiﬁcant genomic
changes, consistent with the phenotypic differences. Five protein
coding changes were observed, which will be discussed individually
below. Furthermore, KOS1.1 showed only two-dozen mutations
relative to KOS, principally single nucleotide insertions or deletions
in homopolymeric stretches. Again, the highest density of changes
was noted toward the middle of UL (Table 1).The UL27 R515H change alters an arginine to histidine on the
long alpha helix of domain III of glycoprotein B (gB) (Heldwein
et al., 2006). Based on this location, the mutation could have an
effect on the refolding of gB from the pre-fusion to the post-fusion
form (E. Heldwein, personal communication). If the prefusion
structure of gB, particularly its helical core, resembles that of VSV
G, then R515 would be in a region that undergoes refolding from
unstructured to helical during fusion, and thus the histidine sub-
stitution might reduce fusogenicity (E. Heldwein, personal com-
munication). Lower fusogenicity of the H515 variant could con-
tribute to an attenuated phenotype. The R515 prefusion form may
be more thermostable and in becoming more thermostable, gB
may have become less able to function in some way that nega-
tively affects its function in neuronal cells.
The RS1 S81P change alters the serine 81 residue of ICP4 to proline.
ICP4 is known to be temperature-sensitive in the F strain (Knipe and
Roizman, unpublished results; Leopardi and Roizman, 1996). There-
fore, this change could have been selected in the KOS1.1 genome to
make the virus better able to replicate at higher temperatures.
The UL30 T566A change in KOS1.1 alters a threonine to alanine
in the 30–50-exonuclease domain of the DNA polymerase catalytic
subunit (Liu et al., 2006). Certain changes in the DNA polymerase
affect the ability of the virus to replicate in sensory neurons (Pelosi
et al., 1998; Terrell et al., 2014). Most importantly, the 30–50 exo-
nuclease domain is known to affect the stability of hyperthermo-
philic archea DNA polymerases (Rodriguez et al., 2000), so this
amino acid residue change could affect the thermostability of the
HSV DNA polymerase.
The UL39 ribonucleotide reductase L393P change could affect the
thermostability of the ribonucleotide reductase large subunit; how-
ever, this enzyme is not required for replication in cell culture, so this
change was not likely to have been selected by plaque puriﬁcation at
high temperature. This change may make KOS1.1 less able to replicate
in neurons. Finally, it is difﬁcult to predict the effect of a change in the
repeat length in the UL36 tegument protein.
In addition to the ORF coding changes, the most common were
sequence length variations within the many stretches of repetitive
or homopolymeric nucleotide sequence found throughout the
HSV-1 genome. In part, the high frequency of these regions simply
reﬂects the low sequence complexity that results from the high-GC
content of the herpes simplex viruses. In addition, some of the
sequence-length variation may result from homologous
Table 4
Alignments of genes where compensating frameshifts occur between HSV-1 KOS and 17.n
n Codon numbers marked relative to the ATG initiator. Predicted amino acid changes are in red.
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This feature could be signiﬁcant for the host immune response
during exposure to a second strain, either via natural super-
infection or challenge of a vaccinated host with a new virus.
We recently observed a pattern of nearby compensating frameshift
mutations in the HSV-2 HG52 reference sequence (Colgrove et al.,
2014), in which a single-nucleotide insertion in one genome is
balanced by single nucleotide deletion a short distance away, resulting
in a run of a few completely different amino-acids ﬂanked by highly
homologous sequence on either side. Such double mutations would
be expected to occur rarely by chance in a DNA virus such as HSV, and
given their absence from other HSV genomes they are most likely
sequencing errors resulting from the limitations of older sequencing
technology with GC-rich, low-complexity regions in HSV. These
changes were also recently noted in the HSV-1 strain 17 sequence
(Szpara et al., 2014) and used to correct the HSV-1 strain 17 reference
sequence (Genbank accession # JN555585.1). This emphasizes the
importance of resequencing and correcting older reference genome
sequences, particularly where high-GC content and low sequence
complexity are issues. Of note, in the particular case of length varia-
tion in homopolymeric runs in 454 sequences, we observed both true
biological variation (i.e. conﬁrmed independently with Sanger
sequences) and sequencing artifact due to limitations of the technol-
ogy. Examination of the raw 454 reads in the latter case showed
variation in number of bases called among individual reads coveringthe same position in the genome. The combined use of Sanger, 454,
and Illumina sequencing here (and comparison with older, manually-
generated sequences)—as well as automated and manual genome
assembly—to generate a ﬁnished sequence for a genome of high GC
content with signiﬁcant repetitive sequence highlights the evolving
state of sequencing technology, with particular strengths and limita-
tions for each (Parsons et al., 2015).
Identiﬁcation of parental KOS viruses
Comparison of the complete genomic sequences of KOS and
KOS1.1 has provided sub-strain speciﬁc genome sequences that
will allow the identiﬁcation of the origin of KOS virus-derived
recombinant or mutant strains. For example, the sequence changes
in the UL27, UL30, UL35, or RS1 genes of the KOS1.1 genome provide
a means to deﬁne whether speciﬁc viruses are derived from a
parental virus similar to KOS or KOS1.1. For example, this could
conﬁrm that the KOS (M) viruses are derived from and similar to
KOS1.1 rather than KOS.
In summary, this study deﬁnes the potential genetic basis for
the different biological phenotypes of the HSV-1 KOS lab strain
and its derivative KOS1.1 sub-strain. The results illustrate the types
of genetic diversity that can be introduced into lab strains as they
are passaged in culture and further plaque-puriﬁed. However, they
also provide the information to determine the provenance of the
R.C. Colgrove et al. / Virology 487 (2016) 215–221220parental KOS viruses used for the construction of speciﬁc KOS-
derived recombinant and mutant viruses, thus allowing the use of
the appropriate wild-type parent virus for comparison. These
results illustrate the need for caution in the comparison of mutant
viruses constructed in different KOS sub-strain backgrounds.Materials and methods
Viruses
HSV-1 KOS passage 12 virus was provided by Priscilla Schaffer.
HSV-1 KOS1.1 was provided by Mike Levine. Both viruses were
grown and titrated on Vero cells.Mouse infections
Mice were housed in accordance with institutional and NIH
guidelines on care and use of animals in research, and all proce-
dures were approved by the Intitutional Animal Care and Use
Committee of Harvard Medical School. Six-week old CD1 male
mice (Charles River Laboratories) were anesthetized in an iso-
ﬂurane chamber followed by deep anesthesia through intraper-
itoneal injections of ketamine (3.7 mg/mouse) and xylazine
hydrochloride (0.5 mg/mouse). Mouse corneas were scariﬁed and
infections were carried out at a dose of 2106 pfu/eye of HSV-1
KOS or HSV-1 KOS 1.1 viruses. Eyeswabs were performed using
sterile polyester applicators (Puritan) at two days postinfection,
and virus shed in tear ﬁlm was titrated on Vero cells. At 30 days
post infection, latently-infected trigeminal ganglia were harvested,
from which DNA was isolated using the Qiagen DNeasy kit and
quantiﬁed using realtime PCR with primers speciﬁc for viral DNA
and a cellular control (Cliffe et al., 2009; Wang et al., 2005).IC
IC
GPrimer SequenceP8 F GAGACCGGGGTTGGGGAATGAATC
P8 R CCCCGGGGGTTGTCTGTGAAGG
APDH F CAGGCGCCCAATACGACCAAAATC
APDH R TTCGACAGTCAGTCAGCCGCATCTTCTTGViral DNA preparation
HSV-1 KOS DNA was prepared as described elsewhere (Col-
grove et al., 2014). Brieﬂy, virus was grown on Vero cells and
depending on the preparation, viral genomes were isolated either
by cell-lysis, or pelleting of extracellular virus from culture
supernatants, followed by SDS/proteinase-K degradation, and DNA
banding in NaI gradients.Shotgun cloning, sequencing and initial assembly
Early rounds of sequencing were carried out using the Qiagen
TOPO Shotgun Subcloning kit, as per the manufacturers instruc-
tions [Qiagen, Germantown, MD]. Subclones were sequenced at
the Harvard Medical School Biopolymers Facility. Initial assembly
was performed using the base-calling, assembly, and ﬁnishing
programs, Phred, Phrap, and Consed [13].454 Sequencing and assembly
Twenty micrograms of KOS DNA were prepared as described
(Colgrove et al., 2014) and submitted for 454 Sequencing to the
Broad Institute [www.broadinstitute.org]. The 454 reads were
assembled using the Newbler suite of tools from Roche/454, using
the runMapping module. The runMapping module performs a
reference-based assembly with the provided reads. The repetitive
nature of the HSV genome made a reference- based approach
better than de novo assembly but still challenged the algorithm.
We broke the reference genome into the major genome compo-
nents: UL, US, RL, and RS. Each component was then used as a
reference in runMapping. The resulting contigs from the repeat
components were duplicated and joined with the unique compo-
nent contigs to form the ﬁnal assembly.
Computer assembly of the genome resulted in creation of a
substantial number of disconnected contigs. Analysis of the contig
ends showed them to be in areas of repetitive sequence where the
software assembler was not able to correctly identify ﬂanking
sequence, either being blocked or adding an incorrect read at the
end. These contigs were joined manually by choosing sequences a
short way in from the end of a contig, searching the raw 454 reads
for that sequence, and then adding reads as appropriate to the
contig in an iterative fashion analogous to chromosomal “walking”
in conventional sequencing. In addition, areas of sequence length
polymorphism in an assembled contig were analyzed by looking
directly at the population of 454 reads covering the corresponding
areas of sequence, typically in homopolymeric runs.
Illumina sequencing and genome ﬁnishing
Ilumina sequencing reads were assembled at the Broad Insti-
tute using ALLPATHS-LG as described previously (Newman et al.,
2015) against scaffolds composed of fragments of the strain 17
sequence corresponding to UL, US, RL, and RS, with 100–200
nucleotides of contiguous sequence at each end. This resulted in
six contigs corresponding to these pieces with breaks in repetitive
sequence in UL36 and RS. Contigs were further reﬁned by manual
insertion of 454 reads at their ends until joining of contigs were
achieved. Gaps in known repeat regions were ﬁlled by adding
repeat numbers by convention with the strain 17 reference
sequence (GenBank accession # NC_001806).
Sequence analysis
Whole genome alignments were performed with Mummer
[http://mummer.sourceforge.net]. Genome annotation was gener-
ated using the online Virus Pathogen Resource [www.viprbc.org],
using HSV-1 Strain 17 as a reference. Individual protein alignments
were done with BLAST [http://blast.ncbi.nlm.nih.gov/Blast.cgi].
Further analysis was carried out using the sequence analysis
package EMBOSS 3.1 [http://emboss.sourceforge.net].Acknowledgments
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